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ABSTRACT
XBP1 AND MIST1 ARE NOT SUFFICIENT TO INDUCE THE REGULATED
SECRETORY PATHWAY IN PAROTID CELL LINES
Ian S. Pyle
October 1st, 2013
BACKGROUND: Xerostomia causes oral infections, tooth decay, and hindered
digestion. Crucial to oral homeostasis is the salivary proteome. How these
proteins are trafficked through secretory cells into secretory pathways is
unknown. Abundant in the saliva is Parotid Secretory Protein (PSP), secreted
through the regulated secretory pathway.
HYPOTHESIS: The addition of XBP-1 and Mist1, known for differentiation marker
regulation, to ParC10 cells will improve stimulated secretion of PSP.
METHODS: Fusion clones were transiently or stably transfected into ParC10
cells. Media from non-stimulated and stimulated cells was harvested and
luciferase activity was assayed.
RESULTS: Stimulated secretion of cypridina-PSP was not significantly higher
than non-stimulated secretion; suggesting cypridina-PSP did not enter the
regulated secretory pathway. Stably transfected ParC10 showed similar results.
CONCLUSION: Cypridina-PSP, XBP-1, and Mist1 did not show stimulated
secretion and thus, no cell differentiation was observed. The ParC10 cells lack a
regulated secretory pathway.
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INTRODUCTION
Xerostomia
Xerostomia, widely known as dry mouth, is a grievous condition affecting
hundreds of millions of people worldwide (Rudney, 1995; Ship, Pillemer, & Baum,
2002). Dry mouth is a condition in which the flow of saliva is diminished (Chan,
Huang, Young, & Lou, 2011; Rudney, 1995). Xerostomia can be caused by a
number of factors or conditions, predominately: medication use, Sjögren's
syndrome, and salivary gland damage or removal due to radiation therapy as
cancer treatment (Baker et al., 2008; Chan, et al., 2011; Hadley et al., 2013;
Shetty, Bhowmick, Castelino, & Babu, 2012; Su et al., 2013; Zhang et al., 2013).
The symptoms of dry mouth are: rampant oral infections, tooth decay,
periodontitis, hindered digestion, and difficulty swallowing, speaking, and tasting
food (Chan, et al., 2011; Gorr, Venkatesh, & Darling, 2005; Shetty, et al., 2012;
Zhang, et al., 2013). Though the fluid nature of saliva is important in the
prevention of the symptoms of dry mouth, the proteins that inundate the saliva,
produced and secreted by the parotid glands, play an essential role in host
protection against infection, digestion, and overall oral homeostasis (Bhalla,
Tandon, & Satyamoorthy, 2010; Heo et al., 2013; Humphrey & Williamson,
2001). It is important to study these proteins and how they are secreted to further
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the understanding of dry mouth, its future cure, and develop novel ways to
alleviate its symptoms.
The Salivary Glands and Specifically the Parotid Gland
The salivary glands are responsible for the synthesis, storage, and
secretion of saliva and all of its proteins. The major salivary glands are: the
sublingual glands, the submandibular glands, and the parotid glands (Baker,
2010; Ho, Lin, Ann, Chu, & Yen, 2011). There is also a multitude of minor
salivary glands throughout the lower facial and upper neck region (Humphrey &
Williamson, 2001). In humans, the parotid glands are located laterally, on either
side of the head, and are distal to the rami of the mandible, and are anterior to
the ears (Ho, et al., 2011). The parotid gland is made of two distinct lobes, a
superficial lobe and a deep lobe called the pharyngeal extension (Gervasio,
D'Orta, Mujahed, & Biasio, 2011). The superficial lobe accounts for two-thirds of
the total parotid gland mass, and the pharyngeal extension comprises the
remaining mass (Gervasio, et al., 2011). Though the facial nerve crosses over
the parotid gland, it does not innervate the gland (Li, Li, Zhang, Yang, & Wu,
2012). Rather, the parotid glands are innervated by the glossopharyngeal nerve
(cranial nerve IX) (Gervasio, et al., 2011). The nerve innervation is solely
autonomic and both para-sympathetic and sympathetic nerves stimulate the
parotid gland.
In rats, the source of the parotid gland cells used in this study, the parotid
glands are located subcutaneously near the midline of the neck lateral to the
trachea. Like human parotid glands, the rat glands are innervated by the
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autonomic nervous system. Sympathetic and parasympathetic nerves stimulate
the salivary glands to secrete salvia, which enters the mouth through ducts. The
parotid gland duct is called Stensen’s duct. Like all salivary ducts, Stensen’s duct
begins as a multi-branched body connecting to scores of acini, which are clusters
of secretory cells, individually called acinar cells (Baker, 2010; Baker et al.,
2010). Generally, single acinar cells secrete saliva and its proteins into the center
of the acinus. The saliva then enters an intercalated duct which then leads to a
striated duct which eventually leads to the salivary duct, i.e. Stensen’s duct, and
thus into the oral cavity.
Saliva and Its Secretion
Saliva is the liquid solution secreted into the oral cavity to help lubricate
and prevent infection of the soft and hard oral tissues (Tran et al., 2013).
Additionally, saliva helps break down food and begin the digestion process.
Critical to the function of saliva is the multitude of proteins that are present (Heo,
et al., 2013).
Current research on saliva shows a salivary proteome of over 2,400
unique proteins (Cabras et al., 2013). Of the large number of proteins found in
the saliva, the most abundant are amylase, Parotid Secretory Protein (PSP), a
family of acidic and basic Proline Rich Proteins, histadin, and statherin (Darling,
2012; Helmerhorst & Oppenheim, 2007). As with all biological systems, the
proteome of the saliva is not constant. Instead, it is quite dynamic (Helmerhorst &
Oppenheim, 2007). From synthesis to secretion, the proteins undergo a myriad
of changes ranging from deglycosylation, cleavage, and protein to protein
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complex formation (Helmerhorst & Oppenheim, 2007). The protein makeup of the
saliva is constantly changing depending on the environment of the oral cavity and
the outer host environment. The saliva is also continually cycled as an individual
swallows and new saliva is secreted into the oral cavity.
The water and mucus portions of saliva are major components, but
henceforth this research paper focuses on the proteins of saliva. Before the
salivary proteins can enter the oral cavity, they have to be sorted within the
individual acinar cell. Exocrine gland acinar cells have several secretion
pathways to traffic proteins within the cell and into the extracellular environment.
In the parotid, these distinct secretion pathways are the major regulated
secretory pathway, minor regulated pathway, apical and basolateral constitutive
secretory pathway, and the constitutive-like secretory pathway (Castle, Huang, &
Castle, 2002; Darling, 2012; Perez, Rowzee, Zheng, Adriaansen, & Baum, 2010).
This research focuses on the difference between two of these pathways, the
apical and basolateral constitutive secretory pathway (constitutive pathway) and
the major regulated secretory pathway (regulated secretory pathway).
Constitutive secretion, that is secretion through the constitutive pathway,
occurs in both the apical and basolateral ends of an exocrine cell. This type of
secretion is continuous and the pathway is always turned on, in such a manner
that secretion occurs regardless of the presence of a stimulus. Even when a cell
is stimulated, the constitutive pathway is turned on and contributing to the total
cell secretion. The proteins secreted via the constitutive pathway first enter
secretory vesicles, which then travel directly from the trans-golgi network to the
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extracellular membrane for exocytosis in both the apical and basolateral ends of
the cell (Gorr, et al., 2005; Kim, Gondre-Lewis, Arnaoutova, & Loh, 2006).
Furthermore, the proteins that enter the constitutive pathway seem to differ from
those found in other pathways. Most likely, these constitutive specific proteins
are used for plasma and extracellular matrix communication; both regions found
abutting the basolateral end of acinar cells.
Conversely, regulated secretion occurs only when the exocrine cell is
exposed to a stimulus. In the parotid gland, the stimulus is either alpha or betaadrenergic neurotransmitters. Regulated secretion, also called stimulated
secretion for the purpose of this thesis, is the release of proteins stored in dense
core secretory granules (DCSG) and these proteins and occurs through the
regulated secretory pathway (Kim, et al., 2006). During unstimulated secretion,
which is through the constitutive pathway, the parotid glands produce and
secrete about 20% of total saliva flow, the remaining secreted by the other
salivary glands (Denny et al., 2008; Humphrey & Williamson, 2001). However,
during stimulated secretion, the salivary flow of parotid glands increases to 50%
of the total flow (Denny, et al., 2008; Humphrey & Williamson, 2001). Regulated
sec Physiologically, stimulated secretion occurs during a meal, yet it is quiescent
between meals (Huang, Castle, Hinton, & Castle, 2001).
Parotid Gland Acinar Cells
Cargo proteins secreted into the parotid saliva are transcribed, translated,
sorted, stored, and secreted by the parotid acinar cells (Venkatesh, Goyal,
Carenbauer, & Darling, 2011). These polarized cells are cone shaped and are
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found in clusters called acini (Baker, 2010) Figures 1A, 1B. In the middle of the
parotid acinus is the duct where the saliva is secreted into and eventually through
the Stensen’s duct and into the oral cavity Figure 1A. Surrounding the acinar
cells are fibroblast cells, nerve endings, and the capillary bed providing the blood
supply.
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Figure 1: Parotid Acinar Cell and Protein Trafficking Pathways

A
B
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Saliva
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Blood
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Figure 1: (A) This is a picture of an acinus (Mills, 2007). An acinar cell is
highlighted in red and Stensen’s duct (salivary duct) is in the center of the acinus.
(B) A cartoon of an acinar cell (Mills, 2007). (C) A cartoon of a commensurate
acinar cell(Gorr, et al., 2005). The bold arrow lines represent the regulated
secretory pathway. The thin arrow lines represent the other various pathways
including the constitutive pathway. Note the constitutive pathway is multidirectional, yet the regulated secretory pathway is uni-directional, specific to the
apical end of the cell.
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Immortalized Parotid Gland Acinar Cells (ParC10 cells)
Ideally, primary rat parotid gland acinar cells would be used to study
regulated secretion. Parotid cells are highly differentiated and are specialized
cells performing very specific functions, such as saliva protein production and
secretion. However, primary cells are difficult to isolate and even more difficult to
sustain for the duration of a transfection experiment. Therefore, our experimental
model used ParC10 cells, which are immortalized rat parotid gland acinar cells
(Quissell, Turner, & Redman, 1998). ParC10 cells are constantly used to study
salivary gland secretion and have been studied extensively (Nelson, Manzella, &
Baker, 2013). ParC10In addition to ParC10 cells, this thesis refers to ParC5 cells,
although they were not used in any experiments described in the results. Though
the two cell lines grew up in separate wells and have some morphological and
growing characteristic differences, they are essentially the same and were
derived from the same immortalization experiment. ParC10 cells grow well in
polystyrene flasks and in cell culture wells, while primary cells rapidly lose the
differentiated phenotype in culture. The immortalized ParC10 cells do originate
from primary rat parotid gland acinar cells, but are instead undifferentiated and
have lost expression of some crucial proteins and transcription factors (Figure 2).
Transcription Factors Missing from ParC10 Cells
It is known that ParC10 cells express lower levels of RNA for proteins and
transcription factors such as amylase and Mist1 than primary rat parotid gland
cells (Figure 2). Mist1 is a class B basic helix loop helix transcription factor
(Yoshida et al., 2001). Mist1 and XBP-1 are two transcription factors thought to
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contribute to the regulation of expression of amylase (Figure 3). It is also known
that both Mist1 and XBP-1 are important for the biogenesis of secretory granules
and other machinery required for the regulated secretory pathway (Lee, Chu,
Iwakoshi, & Glimcher, 2005; Tian et al., 2010). Thus, the addition of Mist1, XBP1, or both to ParC10 cells may help initiate biogenesis of missing machinery
necessary to the regulated secretory pathway.

9

Gene expression (1/fold change)

Figure 2: Gene Expression of Transcription Factors and Differentiation
Markers of Primary Rat Parotid Gland Cells and ParC5 Cells

Figure 2: The above graph represents RNA expression levels of Amylase, Mist1,
PSP, and Tcf12 in primary rat parotid gland cells (violet and purple colored bars)
and ParC5 cells (beige and ice blue colored bars). The y-axis shows the RNA
expression levels as a 1/fold change starting from 10 at the top and going down
10 logs to 1x10-9. ParC5 cells were derived from the same experiment as ParC10
cells. The conclusion of this graph is RNA expression levels for Amylase, Mist1,
and PSP are exponentially less in ParC5 cells than in primary rat parotid gland
cells.
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Figure 3: A Hypothetical Transcription Factor Network for PSP.

Figure 3: This figure shows a hypothetical transcription factor network. Various
transcription factors, in black, help regulated the expression of the differentiation
markers, in red. The hypothetical transcription factor network above suggests
XBP and Mist1 are transcription factors involved in the expression of key parotid
gland cell differentiation markers, amylase, PSP, and Itpr3. This is a working
model in the Darling laboratory.
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Regulated Secretory Pathway
ParC10 cells are not polarized in culture and thus uni-directional regulated
secretion cannot truly occur. However, the cells can be stimulated via an
adrenergic agonist, which turns on the regulated secretory pathway in vivo.
When the stimulant is added to ParC10 cells, for our experimental purposes, the
operational definition of this type of secretion is: "stimulated secretion."
When stimulated in vivo, vesicles containing cargo proteins move to the
apical end of the cell and the proteins are released. These specific vesicles are
called dense-core secretory granules (DCSG). Until stimulated, these DCSGs
are stored and continue to remain in the apical end of the cell, as seen in Figure
1A (Arvan & Castle, 1986; Borgonovo, Ouwendijk, & Solimena, 2006). The
DCSGs are the small dark circles located in the apical, the pointed, end of the
cell (Figure 1A) (Borgonovo, et al., 2006).
Contents of the DCSGs are released, via exocytosis, when Par-C10 cells
receive a beta-adrenergic stimulus (Soltoff & Hedden, 2010). A stimulant used in
previous literature is isoproterenol, which is a beta-adrenergic agonist for the
neurotransmitter epinephrine. The stimulus binds to the Beta-2 adrenergic
receptors, which turn on a G-protein and adenylyl cyclase coupled pathway,
thereupon up-regulating cyclic-adenosine monophosphate (cAMP) and activating
protein kinase A (PKA) (Soltoff & Hedden, 2010; Takuma et al., 2013). This in
turn induces the PKA cascade allowing the release of DCSGs.
Though the DCSGs are packed full of cargo proteins, only certain proteins
are found in these vesicles (Gorr, et al., 2005). Hence, there are some cargo
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proteins that are distinguishable and are directed specifically into the regulated
secretory pathway and into the specific granules. How this particular “protein
sorting” occurs and how specific cargo proteins are directed into the regulated
secretory pathway remains unknown (Courel et al., 2010; Dikeakos &
Reudelhuber, 2007; Folsch, Mattila, & Weisz, 2009; Lord et al., 2011).
Cargo Proteins of the Parotid Gland
During stimulated secretion, the parotid glands contribute all the major
salivary cargo proteins such as amylase, parotid secretory protein (PSP), and
proline rich protein (PRP). These cargo proteins are transcribed and translated
like all proteins. However, also like all proteins, after being directed into the
endoplasmic reticulum (ER) via a signal sequence, the signal sequence of cargo
proteins is cleaved by signal peptidase. Then protein continues to mature and
moves to the trans-golgi network (TGN) and enters the regulated secretory
pathway and is shepherded into secretory vesicles (Badr, Hewett, Breakefield, &
Tannous, 2007; Folsch, et al., 2009; Sobota, Ferraro, Back, Eipper, & Mains,
2006). It is this process, in which the cargo proteins are sorted into the regulated
secretory pathway, that is widely unknown (Courel, et al., 2010; Dikeakos &
Reudelhuber, 2007; Lord, et al., 2011). It is important to note that this process is
unknown for all cargo proteins, secreted from all exocrine glands and this query
is not limited to the parotid glands. It is currently postulated that certain proteins
contain a sorting sequence or structure, different than the signal sequence which
only directs the a nascent protein into the ER and is then cleaved, and it is this
sorting sequence or structure that helps the cell recognize if the protein should
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be directed into the regulated secretory pathway or not (Gorr, et al., 2005).
However, it is important to note, this sequence or structure has not been found
for proteins that enter the regulated secretory pathway, Such as PSP (Gorr, et
al., 2005; Venkatesh, et al., 2011).
Parotid Secretory Protein (PSP)
Rat PSP, known as BPIFA2E, is a member of the
bactericidal/permeability-increasing-fold (BPI-fold) protein superfamily
(Abdolhosseini, Sotsky, Shelar, Joyce, & Gorr, 2012; Bingle & Bingle, 2011;
Darling, 2012; Geetha, Venkatesh, Bingle, Bingle, & Gorr, 2005). This
superfamily includes the protein families: BPI protein, lipopolysaccharide binding
protein (LBP), phospholipid transfer protein (PLTP), and cholesteryl ester transfer
protein (CETP) (Abdolhosseini, et al., 2012; Darling, 2012). This protein is a
member of the palate, lung, and nasal epithelium clone (PLUNC) gene family
and, in humans, the gene is found on chromosome 20q11 (Abdolhosseini, et al.,
2012; Bingle & Bingle, 2011). Recent research suggests human PSP is a LBP
protein, which indicates an anti-inflammatory role (Geetha, et al., 2005).
Additionally, it is documented that recombinant PSP shows anti-bacterial activity
against the Gram-negative bacterium P. aeruginosa (Geetha, et al., 2005;
Geetha, Venkatesh, Dunn, & Gorr, 2003).
PSP is a protein secreted through the regulated secretory pathway that
has antibacterial and anti-inflammatory properties (Geetha, et al., 2003). The
protein is found in both human and rats, as well as pigs and bovine animals
(Gorr, et al., 2005). PSP is only found in the saliva but not serum (Darling, 2012;
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Venkatesh, Tan, Gorr, & Darling, 2007). Thus, PSP must enter the apical
regulated secretory pathway since it is secreted uni-directionally out the apical
end of the acinar cell towards Stensen’s duct and not towards the basolateral
end of the cell.
More evidence PSP enters the regulated secretory pathway is that it is
found in DCSGs (Gorr, et al., 2005; Venkatesh, et al., 2011). Demonstrations
have been made to show PSP binds to Phosphatidylinositol(3,4)bisphosphate
(PtdIns (3,4)P2) very well (Venkatesh, et al., 2011). PtdIns (3,4)P2 is a lipid
primarily found in the TGN and secretory granule membranes.
Of the major cargo proteins secreted by the parotid gland, PSP is a
primary candidate for studying regulated secretion because, in vivo, it only enters
the regulated secretory pathway and is only secreted when stimulated. However,
how PSP enters this pathway is unknown. Furthermore, it is unknown how any
protein enters the regulated secretory pathway of any acinar cell.
Hypothesis
The goal of this research is to establish a working experimental model to
distinguish regulated secretion from other secretion pathways. With this goal in
mind, we can use this experimental model to study how the specific salivary
protein PSP enters the regulated secretory pathway. Considering that ParC10
cells lack transcription factors important to the function of the regulated secretory
pathway, an important goal is to increase their expression and presence in the
cells. The hypothesis is that the addition of XBP-1 and Mist1 to ParC10 cells will
improve stimulated secretion of specific cargo proteins.
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METHODS
Cloning
The overall approach was to tag PSP with luciferase enzymes, making a
quantitative and sensitive way to measure PSP secretion. It was necessary to
synthesize DNA plasmid clones in the laboratory to construct the unique fusion
proteins for our transfection experiments. The plasmid vectors were designed
using Vector NTI software, which showed possible enzyme cut sites and the
primers needed. The desired DNA fragments, were amplified by PCR (MJ
Research PTC-200 thermocycler). This process consisted of 6 minutes of
denaturation at 95º C, 33 cycles of 95º C, 58º C and 72º C, and an extension
time of 10 minutes at 72º C. The PCR product was confirmed by agarose gel
electrophoresis and then cut out of the gel and purified using a Qiagen QIAquick
Gel Extraction Kit.
Then, the purified PCR product was digested with appropriate enzymes,
specific to the DNA fragment and the vector, and ligated into the vector using the
thermocycler. The vectors were then transformed separately into Invitrogen One
Shot Top10 chemically competent bacterial E. coli cells. The cells were put onto
a Luria Bretani broth (LB)/agar plate with ampicillin and left to incubate overnight
at 37º C. Colonies were picked and placed on a master plate and inoculated in
10 mL of LB/ampicillin media over night in a shaker at 37º C. The following day a
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miniprep (Promega Wizardplus SV Miniprep kit) was performed per the
manufacturers instructions to purify the plasmids. The plasmids were then
digested with an enzyme or enzymes to cut the vector in a way to easily identify
whether the DNA fragment was ligated correctly into the vector. This process
usually produced a small and large fragment, which produces bands easy to
distinguish on a gel. The successful plasmids were then sequenced at the
University of Louisville Nucleic Acid Sequencing CGeMM core. Once the
sequences were verified, the colonies with the correct sequences were picked
from the master plate and inoculated in 50 mL of LB/ampicillin media overnight in
a shaker at 37º C. The plasmids were purified using a QIAgen Plasmid Midi Kit.
The final plasmids were sampled in a nanodrop machine to verify no protein
contamination, (!260/280 >1.80) and the amount of DNA in ng/!L.
ParC5 Media Solution
The optimal solution for culturing ParC10 cells is ParC5 media, identical to
the media used for culturing ParC5 cells. One liter of ParC5 media solution
contains: 950 mL double-distilled H20; 10 mL of insulin-tranferrin-selenium-X
(Invitrogen); 1 mL of 1 mM hydrocortisone; 30 !L of 1 mg/mL retinoic acid
solution; 20 !L of 0.1 mM T3 solution; 50 !L of 1.0 mg/mL EGF, 1 mL of 200 mM
L-Glutamine, 1 mL of 50 mg/mL gentamicin; 1 mL of Trace Element Solution
(MPBiomedical); 5 mL of Penn/Strep (Invitrogen); 25 mL of fetal bovine serum
(FBS); 1.25 g of NaHCO3; and 15.6 g of Dulbecco's Modified Eagle Medium-F12.
The solution is adjusted to a pH of 7.3.
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Passaging Cells
ParC10 cells were grown in either a T-25 or T-75 flask in either 5 or 10 mL
of ParC5 media respectively. During growth, the media was exchanged for fresh
media dependant on the pH, determined by color of media, or amount of debris
found in the flask. Cells were passaged when 60-75% confluent. To passage the
cells, the flask was moved to a sterile Forma Scientific laminar flow hood. The
media was aspirated, and 1mL or 0.5mL of trypsin was added to a T-75 flask or
T-25 flask, respectively. The flask was moved to a New Brunswick Scientific
Excella Eco 170 incubator with 5% CO2 and a temperature of 37° C, and
incubated for 4 minutes. 3 or 1.5 mL of ParC5 media was added to the T-75 or T25 flask respectively and the cell-containing solution was pipetted up and down
to break up the cells. A sample of the cell solution was then stained with 50%
trypan blue and counted using a Reichart Bright-Line hemocytometer while
looking through an Olympus CK2 microscope set at 10X magnification. The
resulting cell count was then calculated for cells per mL and the desired cell seed
amount was placed into wells. A sample of the cell solution was placed into a
new flask to complete the passaging process and begin growing a new passage
number of cells.
Transfection
500 !L of ParC5 media was placed in each well of a sterile 24 well plate
(Corning 15.6 mm diameter wells). ParC10 cells were passaged and counted
and were seeded at either 30 k or 20 k cells per well, depending on the particular
experiment. The cells were allowed to incubate at 37° C overnight with 5% CO2.
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The following day, the media was changed and fusion-protein-expressing
plasmids were diluted in Dulbecco's Modified Eagle Medium (DMEM) to the
appropriate amounts for a total of either 500 ng or 200 ng of DNA per well. For
control, pBluescript II KS (+) was used as a filler DNA to maintain a consistent
DNA mass. The plasmids were then added to the wells along with a transfection
lipid reagent, either lipofectamine® or FuGENE HD ®. FuGENE HD ® was used
in a ratio of 1:8, DNA to lipid reagent, respectively. The cells were allowed to
incubate at 37° C overnight in the incubator with 5% CO2. The following day, the
media was aspirated and the cells were prepared for a media harvest.
Transfection Media Harvest
The cells were washed with ParC5 media five times; incubated at 37° C
with 5% CO2 for 5 minutes three times, then again for 30 minutes, and once
more for 5 minutes. The final wash media was aspirated and ParC5 media was
then added to the cells and the plate was incubated at 37° C with 5% CO2 for
thirty minutes. Following the incubation, 400!L of the media was collected as a
basal secretion sample. The sample was centrifuged at ~300 g for 10 minutes to
pellet any stray cells. 300 !L of the top basal secretion sample was collected into
a 1.5 mL Eppendorf tube and stored in 4° C until assay. The remaining 100 !L of
media in the 24 well plate was aspirated and the 500 !L of Parc5 media was
added to each well and the plate was incubated at 37° C with 5% CO2 for five
minutes for a wash. The wash media was aspirated and 500!L of ParC5 media
containing a stimulant was added to each well. The stimulated media was
prepared by adding isoproterenol (30 !M), forskolin (10 !M), carbachol (100
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mM), or a combination of these stimulants. Isoproterenol is an epinephrine
agonist and turns on the cAMP pathway by binding to the beta-adrenergic
receptor, a cellular membrane surface protein. Similarly, forskolin, turns on the
cAMP pathway, but within the cell. The plate was incubated at 37° C with 5%
CO2 for thirty minutes. Following the incubation, 400 !L of the media was
collected into a 1.5 mL Eppendorf tube as a stimulated secretion sample. The
sample was spun at ~300 g for 10 minutes to pellet any stray cells. 300 !L of the
top stimulated secretion sample was collected into a 1.5 mL Eppendorf tube and
stored at 4° C until assay
Assay
To assay the samples of a media harvest, 20 !L amounts of each
harvested media sample was loaded onto a Perkin-Elmer 96 well OptiPlate in
duplicate. A Berthold Centro XS3 LB 960 Luminometer was washed with 70%
EtOH and dionized H2O and then primed with either cypridina or gaussia
luciferase reagent. The relative light unit (RLU) data were displayed and
recorded using MikroWin 2000 software.
Stable Cell Creation
To create the stable cell lines, the desired genes, i.e. Cypridina-PSP,
Cypridina (Cluc-2), XBP, and Mist1 were cloned into the PBQM812-A1 PiggyBac
Tranposon system vector (System Biosciences). The PiggyBac Transposon
system transposes its cloned-in gene into the genome of the transfected cell.
Gene expression can be turned on in the presence of cumate and turned off
when the cumate is removed via the cumate switch. The PiggyBac system also
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transposes a puromycin resistant gene, so successfully transfected and
transposed cells will live in the presence of puromycin. Finally, the system
includes a GFP expressing gene, turned on in the presence of cumate. This
feature gives the user the ability to see successful transposition using a confocal
microscope.
Once the Cypridina-PSP, Cluc-2, XBP, and Mist1 PiggyBac plasmids were
cloned, they were transfected into ParC10 cells, alone or in combination;
including an empty PiggyBac plasmid for a control. The lines and their respective
combinations are listed in the Results section. The cells were then put through a
series of increasing puromycin concentrations to select for the successfully
transfected and transposed cells. Ultimately, the cell lines were checked for
successful transposition via the confocal microscope. Then, they were placed in
liquid nitrogen tanks for long-term storage, or used immediately for secretion
experiments.
Stable Cell Secretion Experiment
The cells were initially plated at 30 k cells per well. The cells were grown
in regular ParC5 media for six hours. Then, the media was aspirated and fresh
ParC5 media containing 3 !g/mL of Puromycin and 10 !g/mL of Cumate was
added until the cells were ready for harvest. The puromycin is necessary
because the PiggyBac vector transposes a puromycin resistant gene to help
select for just stably transfected cells. The Cumate in the media turns on the
Cumate Switch vector so the cells can begin expression of the protein or proteins
inserted into the cell.
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rtPCR
Reverse transcriptase was performed using the High Capacity cDNA Reverse
Transcriptase Kit from Applied Biosystems per the manufacturer’s instructions. A
control tube was made without the reverse transcriptase enzyme. The results
were verified on an agarose gel.
Preparation of Agarose Electrophoresis Gel
DNA samples were analyzed using gel electrophoresis. 1% agarose
electrophoresis gels were made by combining 40 mL of double de-ionized water,
10 mL of 5x Tris/Borate/EDTA (TBE) buffer, and 0.5 g of ME agarose in an
Erlenmeyer flask. The mixture was heated in an Amada RadaRange microwave
oven for 2 minutes, pausing to swirl the flask at 30-second intervals. After
warming, 6 uL of ethidium bromide was added to the mixture and it was then
poured into the gel apparatus. A gel comb was inserted to create slots in the gel
and the mixture was left to cool and harden. Once solid, 6x-loading dye was
added to each sample and then samples and 1kb+ molecular weight marker DNA
ladder (Invitrogen) were added into the gel slots. The gel was run using a
FischerBiotech 105 electrophoresis system set to 148, or 48 volts for low melt
gels, and left for 30minutes to 2 hours. For analysis, gels were placed on a
Fishcer Biotec FBTI 816 312 nm ultraviolet transilluminator and the picture was
captured using the Stratagene Eagle Eye system.
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RESULTS
Synthesis of Clones used for Transient Transfections
The ability to measure a specific protein being secreted out of an exocrine
cell was crucial to designing the experiments used in this research. The other key
was using a secreted protein well known for a specific secretion pathway.
Luciferase proteins, which are readily attached to other proteins via cloning, emit
light when interacting with specific substrates, e.g, luciferin and ATP. The light
produced from the luciferase protein and substrate interaction can be easily
measured. Thus, a luciferase protein was attached to Parotid Secretory Protein
(PSP), which is well documented for only entering the regulated secretory
pathway in parotid gland cells, as mentioned in the introduction. Clones are
inserted into cells by performing a transient transfection. The clone is part of a
plasmid vector, which enters the nucleus of a cell to be transcribed and
translated. After secretory cells manufacture this fusion protein, it is then
secreted into the culture media and the amount of released protein is measured.
The cells used in the following experiments were ParC10 cells. Though
these cells were derived from a rat parotid gland, they had been immortalized
and are to a great extent, undifferentiated. They are polar when grown on transwell filters. In vivo, PSP is secreted through the regulated secretory pathway, but
in the ParC10 cells the pathway for secretion of the fusion protein is unknown.
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Despite being undifferentiated, adding a neurotransmitter agonist to the cells may
stimulate them to secrete the fusion protein in a more in-vivo like manner.
Particularly, the amount of PSP being secreted should increase once a stimulus
has been added. We used the term “stimulated” when the neurotransmitter
agonist was added to the cells. When no stimulant was present, we used the
term “basal,” because in-vivo, constitutive secretion occurs perpetually and at
lower amounts. Therefore, basic cell functions critical to our research can be
controlled and manipulated.
The specific luciferase proteins we used in our transfections are Gaussia
luciferase and Cypridina luciferase. Gaussia luciferase originates from the
copepod called Gaussia Princeps (Welsh, Patel, Manthiram, & Swartz, 2009). It
is a marine crustacean that glows from bioluminescence, caused by the Gaussia
protein interacting with a substrate. Similar to the Gaussia protein is Cypridina
luciferase. Cypridina originates from the ostracod called Cypridina noctiluca and
produces a bioluminescent protein like the Gaussia protein, which also glows in
the presence of a substrate (Nakajima, Kobayashi, Yamagishi, Enomoto, &
Ohmiya, 2004).
The clones and their respective plasmid vectors used for all transient
transfections are listed in Table 1 and Figure 4. The corresponding protein
names are listed in column 4 of Table 1. Each clone in Table 1 displays the
correct sequence and was transformed into One Shot Top10 chemically
competent bacterial Escherichia coli (E. coli) cells.
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Table 1
List of Clones Placed Into the pCMV 6.2 Vector

EXPRESSION
VECTOR

INSERT

FINAL CLONE

PROTEIN NAME

pcDNA 6.2

PSP-Gaussia

ratPSP-Gaussia

PSP-Gau

pcDNA 6.2

SS-rPSP-"SS-Gaussia

pcDNA 6.2-ratSSp- "SSGAU

SSp"SSgau

pCMV

Gaussia

pCMV-Gluc

Gluc

pcDNA 6.2

rPSP-"SS-Cypridina

pcDNA 6.2-ratPSP-"SS

PSP-"SS-CLuc-2

pcDNA 6.2

SSp-"SS-Cypridina

pcDNA 6.2-SSratPSP-"SS-CLuc-2

SSp-"SS-CLuc-2

pcDNA 6.2

Cypridina-"SS-rPSP

pcDNA 6.2-CYP-"SSratPSP

CYP-"SS-PSP

pCMV

CLuc-2 (Cypridina)

pCMV-CLuc-2

CLuc-2

Table 1: The clones listed in table 1 are represented as diagrams in Figure 4.
“SS” refers to the signal sequence of the protein and “"SS” refers to the deletion
of the signal sequence of the protein.
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Figure 4: Fusion Protein Constructs

Figure 4. The above figure represents the various fusion proteins used for the
transient transfections performed for this research paper. The expression vectors
and final protein names can be found listed in Table 1 and each clone shares the
same common letter identifier. The proteins fused to the C terminus of other
proteins are without their signal sequence (SS).
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Measuring Regulated Secretion
Regulated secretion is defined as the release of intracellular and vesicle
bound proteins or chemicals to the extracellular space via the regulated secretory
pathway. To interpret regulated secretion numerically, the stimulated relative light
unit (RLU) values were divided by the unstimulated RLU values, and the resulting
quotient is a ratio, which can help interpret the difference between basal and
regulated secretion. Additionally, the ratio derived (stimulated divided by
unstimulated) controls for well-to-well variation for transfection efficiency since
each experiment is run with triplicate wells. The analyses of the experiments in
this paper define basal secretion, as a ratio of one because the basal secretion
divided by itself is one. Conversely, stimulated secretion is operationally defined
as a value higher than one. Stimulated secretion if present always includes the
perpetual constitutive secretion, which never turns off, even if stimulated. Thus,
stimulated secretion is any ratio higher than one, while one is equal to the basal
secretion.
Figure 5 represents a hypothetical graph representing the raw data from a
secretion experiment. Both the basal and stimulated raw values (RLU or relative
light units) are shown for Cypridina-PSP and the negative control, Cypridina
alone (CLuc-2). The important point to note is the values for both the basal and
stimulated CLuc-2 are equal. However, the values for the basal and stimulated
Cypridina-PSP differ; basal Cypridina-PSP is lower and stimulated CypridinaPSP is higher by four fold.
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Figure 6 represents a hypothetical graph based on the graph in figure 5.
Figure 6 displays the ratio, the result of dividing the stimulated RLU by the basal
RLU for both Cypridina-PSP and Cypridina alone. In Figure 6, the Cypridina
alone ratio is one, because the stimulated value is equal to the basal value. In
theory, the stimulated Cypridina alone RLU value represents only basal secretion
because the stimulus does not evoke a response form the regulated secretory
pathway, but basal secretion continues regardless of the presence of a stimulus.
Though the Cypridina alone expressing cells are stimulated, the Cypridina alone
protein only enters the perpetual constitutive pathway and not the regulated
secretory pathway. Conversely, the ratio of stimulated Cypridina-PSP RLU
divided by basal Cypridina-PSP RLU equals four, because the stimulated value
is about four times the quantity of the basal value. Thus, the stimulus does evoke
a response in the regulated secretory pathway, and the basal secretion continues
regardless of the presence of a stimulus.
In the graph in Figure 6, a green line set at the basal/stimulated ratio of
one represents the defining point at which the secretion occurring is either basal,
below the green line, or stimulated, above the green line. Since Cypridina-PSP
shows a ratio above one and above the green line, basal and stimulated
secretion is occurring. Since Cluc-2 shows a ratio of one, and an average just at
the green line but not above it, only basal secretion is occurring.
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Figure 5: Hypothetical Raw Transfection Data

Figure 5: Theoretical transfection data of a comparison between the negative
control Cluc-2 (blue), and the experimental variable Cyp-PSP (red). (N = 3) In
this hypothetical experiment, both the basal and stimulated results of the
negative control have similar RLU values of 1.2 million. Conversely, the
stimulated values for Cyp-PSP, five million, are much higher than the basal
counterpart values, 1.2 million.
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Figure 6: Hypothetical Stimulated / Basal Ratio Data

Figure 6: The stimulated RLU values were divided by their basal analogues, and
the quotient is a ratio, which can help interpret the difference between basal and
regulated secretion. Basal secretion is defined as a ratio of one. Stimulated
secretion is operationally defined as any value higher than one. It is important to
note that basal secretion is always occurring, even when stimulated secretion is
observed. Cluc2 has a ratio of exactly one, suggesting only basal secretion is
occurring. Cyp-PSP has a ratio of four, suggesting regulated secretion is
observed, and basal secretion is still occurring at one.
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Using Gaussia as a luciferase tag
The goal of this series of experiments was to find a way to distinguish
between basal and stimulated secretion. The hypothesis was the PSP-Gaussia
would show stimulated secretion, while the negative control, the fusion protein of
just the signal sequence of PSP and gaussia (SSp-#SSgaussia), would show no
stimulated secretion, just basal secretion while stimulated.
Triplicate wells, each initially seeded with 45 k ParC10 cells, were each
transfected with 100 ng of the fusion protein clone Gaussia-PSP. In the same
manner, triplicate wells were each transfected with 300 ng of the fusion protein
Gaussia-PSP. Likewise, triplicate wells, each initially seeded with 45 k ParC10
cells, were each transfected with 100 ng of SSp"SS-Gaussia, the negative
control. A fourth set of triplicate wells, each initially seeded with 45 k ParC10
cells, were each transfected with 300 ng of SSp"SS-Gaussia. An additional, 20
ng of CLuc-2, the transfection efficiency measure, was transfected into each well.
To maintain consistency, the filler DNA pBlueScript II KS (+) was used to bring
the total amount of transfection DNA for each well to 500 ng. Lipofectamine™
2000 (Invitrogen) was used as the lipid transfection reagent.
The transfection was performed with a series of washes and the basal and
stimulated media were applied and collected after thirty minutes consecutively.
An assay was performed by first loading 20 !L of each media sample into 12 x
75 mm borsociliate glass tubes in duplicate. Then, the gaussia and cypridina
luciferase solvent, buffer, and substrate solutions were made and loaded into the
luminometer. The assay was performed in a Berthold Lumat 9501 luminomter.
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The average of the three transfection experiments showed both basal and
stimulated secretion are occurring for 300 ng of SSp-#SSgaussia Figure 7.
However, the average of 100 ng of SSp-#SSgaussia is right at the green line and
thus only basal secretion is occurring Figure 7.
The conclusion is SSp#SSgaussia, the negative control may show
regulated secretion. Thus, it is a poor negative control. Additionally, Gaussia
could be the protein with a sorting sequence directing the fusion protein into the
regulated secretory pathway, and this would make it more difficult to discover the
sorting sequence on the PSP protein, with the interference of Gaussia. It is
important to note, while SSp#SSgaussia has the signal sequence of PSP on the
N-terminus, the signal sequence is cleaved by signal peptidase as the protein
enters the endoplasmic reticulum (ER). Thus, the mature gaussia protein was
showing potential stimulated secretion without the influence of PSP. An unbiased
luciferase protein with the ability to be secreted is needed to form a new fusion
protein.
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Figure 7: Gaussia-PSP Shows no Stimulated Secretion

SSp

Figure 7: The graph above represents the average stimulated / basal ratio for
three different secreted proteins, the corresponding genes being transfected into
the cells. The bars represent an N of 1 to 3. Gaussia-PSP showed no stimulated
secretion for both the 100 ng and 300 ng transfected amounts. Likewise the 100
ng of gaussia with the PSP signal sequence attached did not show stimulated
secretion either. The 300 ng of SSp"SSgaussia showed variable but higher
secretion, which may include some stimulated secretion, though the standard
deviation was quite large. Lastly, the gaussia only showed no stimulated
secretion.
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Using Cypridina as a luciferase tag
The transfection efficiency measure protein Cypridina did not show
regulated secretion and therefore was used to make a new luciferase fusion
protein with PSP Figures 4D, E, & F. Cypridina was attached to PSP in two
variants. The first variant was Cypridina attached to the C-terminus of PSP (PSPCypridina) Figure 4D and second, cypridina attached to the N-terminus of PSP
without its signal sequence (Cypridina-PSP) Figure 4F. The two variations are
necessary because one or the other might allow the protein to fold in a way to
prevent the protein from entering the regulated secretory pathway. PSP from
primary cells is not a fusion protein and the attached cypridina might affect the
fold of PSP. Therefore, of the two versions synthesized, one of the recombinant
proteins may be more efficient than the other in entering the regulated secretory
pathway and will be more similar to the in-vivo PSP protein expressed in primary
cells. Furthermore, the signal sequence of PSP was attached to the N-terminus
of Cypridina (SSp#SSCypridina) as a negative control for future experiments
Figure 4E.
The goal of the following series of experiments was to distinguish between
basal and stimulated secretion using a fusion protein of PSP and Cypridina. The
hypothesis was that cypridina-PSP fusion protein would enter the regulated
secretory pathway while the control cypridina protein would not enter the
pathway.
Triplicate wells, each initially seeded with 45 k ParC10 cells growing in
ParC5 media, were each transfected with 100 ng or 300 ng of the fusion protein

34

Cypridina-PSP. Likewise, triplicate wells, were each transfected with 100 ng or
300 ng of PSP-Cypridina. A fifth set of triplicate wells, were each transfected with
300 ng of PSP-Cypridina. Additionally, 50 ng of CLuc-2, was transfected into
triplicate wells. To maintain consistency, the filler DNA pBlueScript II KS (+) was
used to bring the total amount of transfection DNA for each well to 500 ng. The
Lipofectamine™ 2000 (Invitrogen) was used as the lipid transfection reagent.
The transfection was performed with a series of washes and the basal and
stimulated medias were applied and collected after thirty minutes consecutively.
An assay was performed by first loading 20 !L of each media sample in duplicate
onto a 96-well microplate. Then, the Cypridina luciferase solvent, buffer, and
substrate solutions were made and loaded into the luminometer and the assay
was run.
The 300 ng of Cypridina-PSP fusion protein, the Cypridina luciferase tag
is on the N-terminus of PSP sans the signal sequence, showed some stimulated
secretion (Figure 8). The 100 ng of Cypridina-PSP and the 100 ng and 300 ng of
PSP-Cypridina did not show stimulated secretion. In addition, in Figure 8, the 50
ng of Cluc-2, the negative control, did not show stimulated secretion either.
Though an increase in Cyp-PSP was observed, an ANOVA test showed no
significance. Since the Cypridina-PSP fusion protein seemed more efficient than
PSP-Cypridina with a higher stimulated / basal ratio, it was then used for all
future transfection experiments. Though 300 ng of Cypridina-PSP showed some
stimulated secretion, the standard error was still large, so the transfection

35

efficiency was scrutinized and a change in the transfection reagent was made for
the following transfection experiments.
In the previous transfection experiments, lipofectamine was used as a
lipid transfection reagent. However, considering the high rate of cell mortality and
low transfection efficiency of lipofectamine, a different lipid transfection reagent,
FuGENE HD ® (Promega), was used for transfection #13 and all transfections
thereafter. The conditions were optimized, and for all transfections using
FuGENE HD ® (Promega) the total amount of DNA was 200 ng for each well.
With the same goal of distinguishing between basal and stimulated
secretion, another set of experiments was carried using FuGENE HD ®
(Promega) as the transfection reagent. The transfection setup was similar using
100 ng of Cypridina-PSP and either 25 ng or 2.5 ng of Cluc-2 each transfected
into one well of triplicate ParC10 cells. The harvest was carried out in an identical
manner.
In Figure 9, the aggregation of transfections thirteen through nineteen
show Cypridina-PSP with an average stimulated / basal ratio of 1.25. The
average stimulated / basal ratio of SSp#SS-CLuc-2 was 1.05. The aggregation of
transfections fourteen through nineteen show Cypridina-PSP with an average
stimulated / basal ratio of 1.2. Similarly, the average stimulated / basal ratio of
SSp#SS-CLuc-2 was 1.0. None of the averages were statistically significant
based on a paired t-test which had a p-value of 0.12 with N = 7. The conclusion
of this data is that no stimulated secretion is being observed for the Cypridina-
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PSP and likewise, no stimulated secretion is observed with the negative control
SSp#SScypridina.
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Figure 8: Cypridina-PSP and PSP-Cypridina Show No Stimulated Secretion

Figure 8: Regarding transfections 8, 9, & 10, Cyp-PSP and PSP-Cyp displayed
some regulated secretion when compared to the negative control Cluc-2.
However, and ANOVA was performed and there was no significant difference.
N=3, p=0.4
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Figure 9: Cypridina-PSP Shows no Stimulated Secretion

SSp"SS-CLuc-2 25 ng

Figure 9: In transfections 13-19 Cyp-PSP was not significantly higher than the
control, 25 ng of SSp"SScyp, and no regulated secretion was observed. A paired
t-test performed and there was no significant difference, N=7, p=.12
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Addition of Chromogranins to the transfection
In the previous experiments, Cyp-PSP alone did not show regulated
secretion and was never statistically significant from the controls, either Cypridina
alone or SSp"SScyp. Since ParC10 cells are undifferentiated, the addition of
some components present in primary cells might further differentiate the cells
and bolster the regulated secretory pathway. It is known that chromogranins A
and B are involved in the condensing of cargo proteins into granules and granule
formation in primary rat parotid gland cells (Hosaka et al., 2004; Koshimizu,
Cawley, Kim, Yergey, & Loh, 2011). The goal of the following experiments was to
add chromogranins to help secretory granulogenesis, granule formation, and
thus increase the likelihood of seeing stimulated secretion (Inomoto et al., 2007;
Koshimizu, et al., 2011; Koshimizu, Kim, Cawley, & Loh, 2010). The hypothesis
is that cells transfected with both Cypridina-PSP and chromogranin B (CgB) will
show better stimulated secretion than cells transfected with just CLuc-2.
100 ng of the fusion protein Cypridina-PSP was transfected into ParC10
cells as described. 25 ng of Cluc-2 was transfected into ParC10 cells growing in
triplicate wells. 100 ng of Cypridina-PSP and 50 ng of CgB were transfected into
ParC10 cells growing in triplicate wells. 25 ng of Cluc-2 and CgB were
transfected into ParC10 cells. To maintain consistency, the filler DNA pBlueScript
II KS (+) (Stratagene) was used to bring the total amount of transfection DNA for
each well to 200 ng. FuGENE HD ® (Promega) was used as the lipid transfection
reagent.
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Though the average stimulated / basal ratios of Cypridina-PSP with CgB
were slightly above Cypridina-PSP by itself (1.5 and 1.25 respectively), the
standard error was too great for any statistical significance (Figure 10). An
ANOVA was performed and no statistical significance was observed based on a
p-value higher than 0.05. Likewise, Cluc-2 and CgB together had a slightly higher
stimulated / basal ratio than Cluc-2 alone (1.4 and 1.3 respectively), but there
was no statistical significance (Figure 10). The conclusion from this set of data is
Cyprdina-PSP transfected with CgB does not show more or any stimulated
secretion than just Cypridina-PSP transfected alone. Also, Cluc-2, the negative
control, worked accordingly when transfected with CgB and without CgB.

41

Stimulated / Basal Ratio

Figure 10: Chromogranin B Has No Significant Effect on Stimulated
Secretion

Cypridina-PSP

+

+

-

-

Cluc-2

-

-

+

+

Chromogranin B

-

+

-

+

Figure 10: The above graph represents an average of the means of the
stimulated / basal ratio of transfections 22, 23, & 24. The average of CypridinaPSP with CgB was slightly higher than Cypridina-PSP without CgB, but the
standard error was too large for any significant difference. Similarly, the average
of Cluc-2 with CgB was slightly higher than Cluc-2 without CgB, but the standard
error was too large for any significant difference. An ANOVA test confirmed there
was no statistical significance between any of the bars with a p-value higher than
0.05.
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Using Forskolin as the Stimulant
Considering the lack of regulated secretion observed in prior experiments,
the isoproterenol could be insufficient for the observation of a robust secretion
reaction. This thought was emphasized due to the use of trypsin (0.25%) to
passage and plate cells. Trypsin hydrolyses the outer cellular membrane proteins
by cleaving arginine and lysine amino acid residues. The targeted proteins to be
hydrolyzed are cell adhesion proteins, but trypsin also hydrolyses other proteins
on the outer cell surface such as the beta-adrenergic receptors, which bind
isoproterenol. Hence, in the past experiments, the possible lack of isoproterenol
binding receptors may have prevented a significant and in vivo-like stimulation
reaction. An alternative stimulant to isoproterenol is the stimulant forskolin, which
activates the same cAMP pathway as isoproterenol, but does so intracellularly.
The transfection experiments were carried out in a similar manner as
previous. Triplicate wells, each initially seeded with 45 k ParC10 cells growing in
ParC5 media, were each transfected with 100 ng of the fusion protein CypridinaPSP. Likewise, triplicate wells, were each transfected with 25 ng of Cluc-2. To
maintain consistency, the filler DNA pBlueScript II KS (+) was used to bring the
total amount of transfection DNA for each well to 200 ng. The FuGENE HD ®
(Promega) was used as the lipid transfection reagent.
The aggregate of transfections thirty through thirty-four showed the
stimulated / basal ratio for Cyp-PSP to be 1.2 and Cluc-2 to be 1.1 (Figure 11).
However, a t-test gave a p-value of 0.29, thus there was no statistical
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significance between the two. Thus, no stimulated secretion was seen for either
Cyp-PSP, or the negative control, Cluc-2.
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Figure 11: Forskolin Does Not Improve Stimulated Secretion

Cypridina-PSP 100 ng

SSp"SScyp 25 ng

Figure 11: In transfections 30 – 34, Cyp-PSP did not demonstrate regulated
secretion with an average stimulated / basal ratio of 1.2. Similarly, the negative
control SSp"SScyp did not demonstrate regulated secretion with an average
stimulated / basal ratio of 1.1. The data was analyzed using a t-test, N=5, p=.29
and thus the data was not statistically significant.
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Stable Cell Lines
The previous transient transfections showed little to no stimulated
secretion and in many instances the negative control showed similar results to
the experimental variable. Even with the addition of chromogranins, known for
their role in dense core secretory granule formation, little to no stimulated
secretion was observed. The cells used, ParC10 cells, are also known for lacking
differentiation. Instead of performing more transient transfections, stable
transfections might help the ParC10 cells to differentiate further by adding XBP
and Mist1.
The vector used to create the stable cell lines is a cumate induced
piggybac transposon system. Plasmid maps of the five clones inserted into the
piggybac vector and used in stable cell creation are shown in Figure 12. The
clones used for stable cell secretion experiments are listed in Table 2. The
protein or proteins expressed in each line are listed in the fourth column of Table
2.
Stable cell lines were created to induce differentiation of the ParC10 cells.
Stable cell lines also reduce the secretion experiment time because the cells
already contain the recombinant DNA, which has been integrated into the cell’s
genome, as opposed to a transfected plasmid. Seven different cell lines were
made using Cypridina-PSP, Cluc-2, transcription factors XBP and Mist1, and one
empty or “vector only,” negative control cell line Table 2.
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Figure 12: Plasmid Maps of the PiggyBac Clones for Stable Transfection

Figure 12: The Cyp-PSP, Cluc-2, Mist-1, and XBP cDNA fragments were cloned
separately into PBQM812-A1 (PiggyBac Transponson System, SystemBio)
vectors.
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Table 2:
Stable Cell Lines and the Genes they Contain

Cell Line:

Mixed or Isolate

Transfected Genes:

A

Mixed

Cyp-PSP

Cyp-PSP

B

Mixed

Cyp-PSP

Cyp-PSP

C

Mixed

Cypridina

CLuc-2

D

Mixed

Cyp-PSP, XBP, Mist1

Cyp-PSP, XBP, Mist1

E

Mixed

Cyp-PSP, XBP, Mist1

Cyp-PSP, XBP, Mist1

E2

Isolate

Cyp-PSP, XBP, Mist1

Cyp-PSP, XBP, Mist1

F

Mixed

*empty vector

*no protein
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Protein Name

Stable Line Secretion Harvest, Cyp-PSP as experiment and Cypridina as
Negative Control
The goal of the following series of experiments was to observe stimulated
secretion and distinguish it from basal secretion. The hypothesis is that
stimulated secretion will be seen with the E2 cell line, and only basal secretion
will be observed with the C cell line, the negative control.
The secretion experiment was setup similarly to the previous transient
transfections, but the initial cell count was reduced to 30 k cells per well. The
cells were grown with regular ParC5 media for six hours, and then the media was
changed to ParC5 media containing puromycin and cumate. The puromycin is to
maintain only transposed cells, for the inserted cassette contains a puromycin
resistance gene. The cumate is used to turn on the expression of the clone
transposed into the genome. After the cells grew to ~70% confluence, the
secretion harvest was performed with a series of washes, and the basal and
stimulated media was collected after thirty minutes consecutively. An assay was
performed by loading 20 !L of each media sample in duplicate into a 96-well
microplate. Then, the cypridina luciferase solvent, buffer, and substrate solutions
were made and loaded into the luminometer and the assay was run.
The E2 cell line showed an average stimulated / basal ratio of 1.4 and the
C cell line (Cypridina only) showed an average stimulated / basal ratio of 1.25
Figure 13. An unpaired T-test of these two averages showed no significant
differences. A different series of experiments was run using isoproterenol (30
!M), forskolin (10 !M), or both stimulants together (Figure 14). The average
stimulated / basal ratios for the E2 cell line using IPR, Forskolin, or both was 2.4,
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2.0, and 2.0 respectively. The average stimulated / basal ratios for the C cell line
using IPR, Forskolin, or both was 1.8, 1.4, and 1.3 respectively. After performing
a two-tailed paired t-test between each pair of E2 and C cell lines stimulated
similarly, no significant difference was found.
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FIGURE 13: Cell Line E2 Shows no Stimulated Secretion

Figure 13: The graph above represents the average of the means of the
stimulated / basal ratio of secretion experiments 17, 18, and 19, using stable cell
lines. Cell line E2 did show an average ratio of 1.4, indicating stimulated
secretion, but the standard error was too great for significance over the Cell line
C control. A paired two-tailed t-test was performed and yielded a p value less
than .05, but due to the variation among separate experiments, an unpaired t-test
was used. The unpaired t-test yielded a p value of 0.67, N=3.
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Figure 14: Comparison of Stimulants with Stable Cells

NS
NS
NS

Figure 14:
The graph above represents the average of the means of the stimulated / basal
ratio of secretion experiments 20, 21, 23, & 25, using stable cell lines. Cell line E2
showed stimulated secretion with a stimulated / basal ratio of 2 or over for each
stimulant setup of IPR alone, Forskolin alone, or a combination of both. However,
cell line C also showed some stimulated secretion when either IPR or forskolin
were used alone. Cell line C did not show stimulated secretion with the
combination of both stimulants. Nevertheless, based on a two tailed paired t-test
the differences between cell line E2 and its correspondingly stimulated control,
cell line C, were never statistically significant, the p-value was more than 0.05
with an N or 3 or 4.
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Addition of XBP and Mist1 to help differentiate ParC10 cells
Due to the lack of differentiation of immortalized ParC10 cells, the lack of
normal expression of crucial proteins may be preventing the primary cell-like full
function of the regulated secretory pathway. The expression of the transcription
factor Mist1 is abated in ParC5 cells, when compared directly to primary rat
parotid gland cells Figure 2. Thus, reintroducing XBP-1 and Mist1 to ParC10 cells
may help make the regulated secretory pathway become more robust and
facilitate regulated secretion of Cypridina-PSP. Using stable cell lines to
reintroduce XBP-1 and Mist1 to ParC10 cells is important because the cells
express these transcription factors for a longer period of time during a stable
transfection secretion experiment than if transiently transfected.
The goal of this series of experiments was to determine if the presence of
XBP and Mist1 transcription factors help increase stimulated secretion. The
hypothesis was the D, E, and E2 cell lines show higher stimulated secretion than
the A and B cell lines Table 2.
The secretion experiment was setup with an initial cell count of 30 k cells
per well. The cells were grown with regular ParC5 media for six hours, and then
the media was changed with ParC5 media containing puromycin and cumate.
After the cells grew to ~70% confluence, the secretion harvest was performed
with a series of washes and the basal and stimulated medias were applied and
collected after thirty minutes consecutively. An assay was performed by loading
20 !L of each media sample in duplicated to a 96-well microplate. Then, the
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cypridina luciferase solvent, buffer, and substrate solutions were made and
loaded into the luminometer and the assay was run.
In a comparison of secretion experiments 12, 14, 15, and 18, Figure 15
cell lines A and B show a stimulated / basal ratio of 1.1 and 0.7 respectively. In
the same series of experiments, cell lines D, E, and E2 show a stimulated / basal
ratio of 0.7, 0.5, and 1.25 respectively. The control cell line C, shows a ratio of
0.7. Though the E2 cell line shows some stimulated secretion, a 1 way ANOVA
test was performed and no significance was observed with a p-value of 0.13.
Additionally, an unpaired one-tail T-test was performed between the average for
the A cell line and the E2 cell line and no significance was detected.
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FIGURE 15: Comparison of Stable Cell Line Stimulated / Basal Ratio

Figure 15: The graph above shows the average of the means of the stimulated /
basal ratios of secretion experiments 12, 14, 15, and 18. An ANOVA was
performed and none of the cell lines showed a significant difference from the
control. The p-value was 0.13 and the N = 4.
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Verification of the expression of XBP and Mist1 in the D, E, and E2 cell lines
It can be determined that the piggybac vector successfully integrated both
the puromycin resistant gene and the Cypridina-PSP gene into the genome of
ParC10 cells because the cells grew in ParC5 media containing puromycin, and
a Cypridina RLU signal was seen above background in all secretion experiments.
However, XBP and Mist1 expression cannot be verified with an assay or simple
growth means. Thus, the goal of this experiment was to verify the expression of
XBP and Mist1 in the D, E, and E2 cell lines.
The A, C, D, E, and E2 cell lines were grown in T-25 flasks in ParC5
media containing puromycin and cumate. After reaching about 70% confluence,
the media was aspirated and the cells were harvested with TRIzol reagent and
RNA isolation was performed. Following the RNA isolation, rtPCR was performed
with control groups not containing the reverse transcriptase enzyme. The product
cDNA was then amplified using PCR supermix and primers for the XBP, Mist1,
and Cyp-PSP plasmids separately. After amplification, loading dye was added
and the samples were loaded onto a 1% agarose gel with 1 kb DNA ladder for
molecular weight reference. The gel was run at 140 volts for 45 minutes.
Figure 16 shows the 1% agarose gel containing 1kb+ DNA ladder,
amplified cDNA, synthesized from RNA from cell lines A, D, and E2. The
columns for cell line A show no presence of XBP or Mist1 and the negative
control columns, reverse transcriptase enzyme was not added to the control, for
cell line A show no amplification of genomic DNA. The columns for cell line D
show the presence of XBP while the negative controls show no cDNA presence.
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Lastly, the columns for cell line E2 show the presence of XBP, yet the negative
controls show no amplification.
The conclusion is cell lines D and E2 do show expression of XBP RNA, as
they should because XBP was transfected into these particular cell lines Table 2.
Yet, cell line A does not show XBP RNA expression, as XBP was not transfected
into this line Table 2. Nevertheless, cells lines D and E2 do not show higher
stimulated secretion than cell line A Figure 15, even though D and E2 contain
XBP, which is known to promote biogenesis of regulated secretory pathway
components.
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Figure 16: Gel Electrophoresis: Cell lines D and E2 Express XBP-1
1 kb Mist1 XBP Cyp
plus RT+ RT+ PSP
RT+
ladder

1 kb Mist1 XBP Cyp
plus RT+ RT+ PSP
RT+
ladder

1 kb Mist1 XBP Cyp
plus RT+ RT+ PSP
RT+
ladder

Mist1 XBP Cyp
RT- RT- PSP
RT-

Mist1 XBP Cyp
RT- RT- PSP
RT-

Mist1 XBP Cyp
RT- RT- PSP
RT-

Figure 16: The pictures above are from a 1% agarose gel. RNA was extracted
from cell lines A, D, and E2, converted to cDNA and the specific transcription
factors Mist1, XBP, and Cyp-PSP were amplified. XBP is ~650 bp. Cell line A
shows no XBP expression, as it should. Cell lines D and E2 show XBP
expression.
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Discussion
To date, the mechanism for how cargo proteins enter the regulated
secretory pathway is unknown. Discovering the mechanism of “protein trafficking”
would benefit both the scientific and medical communities because the regulated
secretory pathway is found in all major exocrine cell types. Clinically eminent
conditions such as diabetes and xerostomia are directly associated with these
cell types that maintain the regulated secretory pathway. Additionally, a greater
understanding of protein trafficking could make therapeutic models more reliable.
Current literature describes various secretory pathways in exocrine cells;
two focal pathways for this paper being the constitutive and regulated secretory
pathways. Our experimental model attempts to distinguish between these two
pathways with the understanding the constitutive pathway never turns off, even
when stimulated. Conversely, the regulated secretory pathway only turns on in
the presence of a stimulus. With this knowledge, we designed the secretion
experiments so we could measure both the constitutive secretion and the
stimulated secretion and then compare the two.
Equally important to our experimental model is the observation that PSP is
only found in the saliva and not the blood, suggesting it only enters the apical
regulated secretory pathway (Darling, 2012; Venkatesh, et al., 2007). While PSP
is only found in saliva, other prominent salivary proteins such as amylase are
found in both the saliva and blood, suggesting PSP is unique and this
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characteristic is advantageous for our study. These findings were the result of a
western blot analysis of rat serum; traces of amylase were found but PSP was
not(Darling, 2012; Venkatesh, et al., 2007). With a luciferase protein attached to
PSP, it would be only the PSP portion of the fusion protein signaling for entrance
into the regulated secretory pathway. Our original question was which part of the
PSP protein is responsible for signaling the regulated secretory pathway.
In the beginning of this research, luciferase protein Gaussia may have
been directing the Gaussia-PSP fusion protein into the stimulated pathway on its
own accord. It is possible that Gaussia has a sorting sequence directing itself into
the regulated secretory pathway. To continue using Gaussia as the luciferase
protein fused to PSP would be bias. In other words, if stimulated secretion was
seen with Gaussia-PSP, we would not know if it was the PSP portion of the
fusion protein directing itself into the stimulated pathway, or if it was the Gaussia
portion directing the fusion protein into the pathway. Consequently, we switched
the fusion luciferase protein to cypridina, which had previously not shown any
stimulated secretion.
Unlike Gaussia, Cypridina alone, (Cluc-2), did not show any stimulated
secretion, so it proved to be a good negative control. The experiments following
the switch to using Cypridina as the luciferase fused to PSP showed no
significant stimulated secretion. So, with a good negative control, effort was
made to push the use of Cypridina-PSP and Cluc-2 forward as the primary
independent variables. The following experiments used Cypridina-PSP and Cluc-
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2, but had additional factors either added or changed to promote the secretion of
the cell in some way.
Chromoganin B (CgB), known for its role in dense secretory core granule
(DCSG) formation was added the transfection with Cypridina-PSP (Koshimizu, et
al., 2011). It was thought CgB would help increase DCSG formation and thus
allow more Cypridina-PSP to enter and be stored in the DCSGs. The current
literature shows chromogranins added to cells increases DCSG biogenesis. By
adding Chromogranin B, a greater amount of Cypridina-PSP would be stored.
Thus, after stimulus treatment, more Cypridina-PSP would be released and more
stimulated secretion would be observed. Our results showed CgB did not
increase stimulated secretion of Cypridina-PSP, nor did it increase the stimulated
secretion of Cluc-2. Similarly, in the current literature there is evidence that
expression of Chromogranin A, known for its involvement in DCSG synthesis,
could not restore the regulated secretory pathway in PC12-27 cells (Kim, et al.,
2006; Malosio, Giordano, Laslop, & Meldolesi, 2004).
Isoproterenol, the neurotransmitter epinephrine agonist used to stimulate
the ParC10 cells, binds to #-adrenergic receptors on the cell surface. During
passaging of the cells, trypsin is used, and it was thought the trypsin might digest
the surface receptors. Forskolin, a #-adrenergic agonist that turns on the
stimulated pathway intracellularly, was used instead of isoproterenol to bypass
the possible lack of receptors on the cell surface. The hypothesis was the use of
forskolin, as a stimulant, would allow Cypridina-PSP to show stimulated
secretion. The results from the experiments using forskolin were negative and
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Cypridina-PSP showed no stimulated secretion. At this point, the focus turned
more to the ParC10 cells and their lack of differentiation.
For the next set of experiments, we followed the same model of
transfecting Cypridina-PSP into ParC10 cells, but instead of performing transient
transfections, we performed stable transfections. By integrating the CypridinaPSP, XBP-1, and Mist1 genes into the genome of the ParC10 cells, they have
the potential to induce some differentiation of the cells. Using stable cells was
crucial because XBP-1 and Mist1 needed time to express and help facilitate the
differentiation of the cells. The time frame for a transcription factors to act on and
regulate differentiation factors is too short during transient transfections, but long
enough during stably transfected cell secretion experiments. Additionally, the
transfection efficiency is increased greatly because theoretically, only the stably
transfected cells live since there is a puromycin resistance gene in the vector,
and the antibiotic is added to the cell media.
The hypothesis was that Cypridina-PSP would show stimulated secretion
in the cell lines it where it was expressed, cell lines A, B, D, E, and E2. The
results from the stable transfection secretion experiments did not show significant
Cypridina-PSP stimulated secretion. The negative control, cell line C, did not
show stimulated secretion.
The stable cell lines created included cell lines with transcription factors
thought to have important roles in differentiation of exocrine cells (Lee, et al.,
2005; Tian, et al., 2010). These transcription factors are XBP and Mist1. Both
were included in cell lines D and E and consequently were included in the
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isolated cell line E2. The E2 cell line is isolated because it was developed from a
single colony of the E cells, thus each individual cell should have genes XBP-1,
Mist1, and Cyp-PSP integrated in the same location on the chromosomes. Since
XBP-1 and Mist1 are transcription factors found in primary rat parotid gland cells,
their presence should help differentiate the cells in which they are expressed.
More importantly, these factors are associated with PSP gene expression, so
they should help bolster the regulated secretory pathway that PSP normally
enters in primary cells.
The hypothesis for the secretion experiments 12, 14, 15, and 18 was the
cell lines expressing Cypridina-PSP, XBP, and Mist1 (cell lines D, E, and E2)
would show better stimulated secretion than the cell lines expressing just
Cypridina-PSP (cell lines A and B). The results did not show any significant
difference between the cell lines with just Cypridina-PSP and the cell lines with
Cypridina-PSP, XBP, and Mist1. The conclusion from this set of experiments is
that these additional transcription factors do not help augment the regulated
secretory pathway to the level where constitutive and stimulated secretion
pathways are distinguishable.
The overall conclusion to be drawn from all of the experiments performed
for this research paper is that the ParC10 cells lack a robust regulated secretory
pathway. Even with the addition of transcription factors and proteins known for
their involvement in the regulated secretory process, the level of differentiation is
too far removed from primary cells and their respective processes. An
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immortalized parotid cell line carrying many more transcription factors and
primary cellular processes is needed.
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